New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
October 31, 2014
06:21 EDTADNCAudience downgraded to Sector Perform from Outperform at Pacific Crest
Subscribe for More Information
06:12 EDTADNCAudience downgraded to Hold from Buy at Topeka
Topeka downgraded Audience to Hold following the Q3 report and lowered guidance. Price target is $6.
October 30, 2014
16:52 EDTADNCAudience sees Q4 adjusted EPS (53c)-(47c), consensus (30c)
Subscribe for More Information
16:51 EDTADNCAudience reports Q3 adjusted EPS (35c), consensus (39c)
Subscribe for More Information
16:21 EDTGDOTGreen Dot raises FY14 adjusted EPS to $1.29-$1.33 from $1.25-$1.29
Subscribe for More Information
16:19 EDTGDOTGreen Dot raises FY14 outlook
Subscribe for More Information
16:18 EDTGDOTGreen Dot reports Q3 adjusted EPS 36c, consensus 28c
Subscribe for More Information
16:00 EDTNFLXOptions Update; October 30, 2014
Subscribe for More Information
12:00 EDTMATMattel division, American Girl, expands into Mexico
Subscribe for More Information
08:14 EDTALKSAlkermes proprietary programs remain on track, says Leerink
Subscribe for More Information
08:09 EDTALKSAlkermes pipeline value set to come into focus, says FBR Capital
FBR Capital says investor sentiment toward Alkermes will "meaningfully shift" over the next 18 months as results from key trials become available. With an FDA action date of August 22, 2015, FBR believes the commercial potential of aripiprazole lauroxil may not be known until 2016. It thinks the 2016 results from the Phase III program of ALKS 5461, a potential treatment for major depressive disorder, may be more important. It sees the company's pipeline value coming into focus over the next six to 18 months and keeps a Market Perform rating on Alkermes following the company's Q3 results.
07:15 EDTMRKASCO / ASTRO / IASLC to hold symposium
Subscribe for More Information
October 29, 2014
16:02 EDTNFLXOptions Update; October 29, 2014
Subscribe for More Information
10:20 EDTGDOTHigh option volume stocks
High option volume stocks: KCG OI SWI SNY ITUB AWI GDOT PNRA EA ZLTQ
09:19 EDTMCKOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Goodyear Tire (GT), up 10%... Electronic Arts (EA), up 3.7%... ZELTIQ (ZLTQ), up 9%... Eaton (ETN), up 2.3%... Anadarko (APC), up 2%... U.S. Steel (X), up 7.7%... IAC (IACI), up 3.6%. ALSO HIGHER: Fiat Chrysler (FCAU), up 12% after reporting quarterly results, announcing plan to spin off Ferrari... Cara Therapeutics (CARA), up 17.8% after HAL trial of IV formulation of CR845 met primary endpoint... Jamba (JMBA), up 4% after upgraded at Wedbush. DOWN AFTER EARNINGS: Facebook (FB), down 5.7%... Gilead (GILD), down 3.2%... Ralph Lauren (RL), down 2.3%... SodaStream (SODA), down 3%... Garmin (GRMN), down 5%... Applied Micro Circuits (AMCC), down 9.9%... STMicroelectronics (STM), down 10%... Ballard Power (BLDP), down 8.7%... Hershey (HSY), down 3.3%... Deutsche Bank (DB), down 2.3%... McKesson (MCK), down 2%. ALSO LOWER: Sanofi (SNY), down 5.7% after downgraded at various firms including Barclays and BofA/Merrill after the company's board removed Christopher Viehbacher as CEO... InvenSense (INVN), down 22%, downgraded at Pacific Crest, Northland and Piper Jaffray following the company's Q2 earnings results... CareTrust REIT (CTRE), down 3.6% after acquiring Cross Healthcare Seniors housing portfolio... Orbital (ORB), down 16% after Orb-3 launch mishap... American Realty (ARCP), down 22% after announcing resignations of CFO, CAO.
08:22 EDTMRKMerck weakness creates buying opportunity, says Argus
After Merck's stock fell 2.6% over the past quarter, Argus is upbeat on the company's Phase III pipeline and finds the stock's dividend attractive. It keeps a Buy rating on the shares.
07:24 EDTMCKMcKesson price target raised to $240 from $220 at Leerink
Subscribe for More Information
07:13 EDTALKSAlkermes reports Q3 AMPYRA, FAMPYRA revenues $16.5M
Subscribe for More Information
07:11 EDTALKSAlkermes says entering Q4 with 'strong momentum'
Subscribe for More Information
07:09 EDTALKSAlkermes sees FY14 free cash flow $20M
Subscribe for More Information
07:05 EDTALKSAlkermes sees FY14 EPS 19c-32c consensus 27c
Subscribe for More Information
07:04 EDTALKSAlkermes reports Q3 EPS 3c, consensus 2c
Subscribe for More Information
06:05 EDTNFLXStocks with implied volatility below IV index mean; UNP NFLX
Subscribe for More Information
October 28, 2014
16:31 EDTMCKMcKesson sees FY15 adjusted EPS $10.50-$10.90, consensus $10.81
16:30 EDTMCKMcKesson reports Q2 adjusted EPS $2.79, consensus $2.73
Reports Q2 revenue $44.8B, consensus $42.99B.
16:00 EDTMRK, NFLXOptions Update; October 28, 2014
Subscribe for More Information
10:08 EDTCTRPCtrip.com threatened by Alibaba partnership with Shiji, Forbes says
Subscribe for More Information
09:37 EDTMRKActive equity options trading
Subscribe for More Information
07:27 EDTMRKFDA PDUFA Date for Merck's MK-3475 is October 28, 2014
Subscribe for More Information
07:16 EDTMRKInvestors overlooking Merck positive points, says SunTrust
Subscribe for More Information
October 27, 2014
20:54 EDTMRKLeerink's major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
16:36 EDTMRKOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTNFLXOptions Update; October 27, 2014
iPath S&P 500 VIX Short-Term Futures down 52c to 32.66. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX GILD CLF PBR according to Track Data.
09:37 EDTMRKMerck slips lower after results, levels to watch
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL PBR TWTR AMZN M NQ GILD C FB NFLX
08:30 EDTMRKMerck sees FY14 gross margin slightly lower vs. FY13
Subscribe for More Information
07:29 EDTMRKWorldwide Business Research to hold a conference
ProcureCon Pharma 2014 is being held in Philadelphia on October 27-29.
07:28 EDTMCKMedical Group Management Association to hold a conference
Subscribe for More Information
07:06 EDTMRKMerck reports Q3 Pharmaceutical sales down 4% to $9.13B
Subscribe for More Information
07:03 EDTMRKMerck narrows 2014 EPS outlook to $3.46-$3.50, consensus $3.47
Now sees 2014 revenue $42.4B-$42.8B, consensus $42.55B.
07:01 EDTMRKMerck reports Q3 EPS ex-items 90c, consensus 88c
Subscribe for More Information
06:46 EDTMRKMerck granted Breakthrough Therapy Designation for KEYTRUDA by FDA
Subscribe for More Information
06:15 EDTNFLXStocks with implied volatility below IV index mean; NFLX CREE
Subscribe for More Information
October 24, 2014
16:02 EDTNFLXOptions Update; October 24, 2014
Subscribe for More Information
13:35 EDTMRKMerck weekly volatility elevated into Q3 and outlook
Subscribe for More Information
08:41 EDTLTMLife Time Fitness will convert to REIT, says Stifel
Following Life Time Fitness' Q3 results conference call, Stifel says the question is not if but when the company will convert to a REIT. The firm notes that the company's revenue comp guidance has improved, and it thinks the business is well-positioned to deliver enhanced returns going forward. The firm keeps a Buy rating on the shares.
October 23, 2014
11:21 EDTMATMattel to host analyst day
Analyst Day to be held in New York on October 30 at 9:30 am. Webcast Link
10:42 EDTLTMHigh option volume stocks
High option volume stocks: ALIM ROC CAKE MDXG SMH CFX CRI INFN LTM
09:39 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:08 EDTLTMLife Time Fitness narrows FY14 EPS view to $3.03-$3.08 from $3.00-$3.10
Subscribe for More Information
08:07 EDTLTMLife Time Fitness reports Q3 adjusted EPS 88c, consensus 86c
Subscribe for More Information
06:51 EDTALKSAlkermes concerns removed with FDA acceptance, says Citigroup
Subscribe for More Information
October 22, 2014
16:00 EDTNFLXOptions Update; October 23, 2014
Subscribe for More Information
13:06 EDTNFLXEarnings Preview: Comcast reporting Q3 results as Time Warner deal progressing
Comcast (CMCSA, CMCSK) is set to report third quarter earnings before the market open on Thursday, October 23, with a conference call scheduled for 8:30 am ET. Comcast is a diversified media company that operates the NBC family of networks and Universal Pictures, among other cable, internet, and voice services. On February 13, Comcast announced plans to merge with Time Warner Cable (TWC) in a deal valued at $45.2B. EXPECTATIONS: Analysts are looking for earnings per share of 71c on revenue of $16.82B, according to First Call. The consensus range for EPS is 64c-76c on revenue of $16.5B-$17.17B. LAST QUARTER: Comcast reported second quarter EPS of 75c against estimates for 72c, on revenue of $16.84B against estimates for $16.95B. TIME WARNER CABLE DEAL: On August 17, The Wall Street Journal reported that the Federal Communications Commission said that one issue it must decide as it reviewed the proposed acquisition of Time Warner Cable is whether to allow Comcast to continue Time Warner Cable's arrangement to handle programming and technology acquisitions for cable operator Bright House Networks. On August 26, Engadget reported that Netflix (NFLX) filed a formal protest against the Time Warner Cable deal, saying that the merger would result in "serious public interest harm" and that a combined cable giant would have a huge amount of leverage over it and rivals such as Hulu. Hulu is a joint venture owned by Comcast along with Disney (DIS) and 21st Century Fox (FOX,FOXA). The New York Post reported on September 8 that Discovery (DISCA) believed Comcast's takeover of Time Warner Cable would give the merged entity an unfair advantage over programmers. That same day, Reuters said a proxy statement detailed that Time Warner Cable employees would split $416M if the merger deal with Comcast did not transpire. At the Goldman Sachs Communacopia Conference on September 10, Comcast said that it has made "a lot of progress" on the shareholder approval process for the Time Warner Cable deal, but expected the agreement to be finalized in early fiscal year 2015 versus the previous guidance of late 2014. The company expects the Time Warner Cable merger to generate $1.5B in operating expense synergies. On September 16, Comcast said at the Media, Communications and Entertainment Conference that it would reveal its capital plan at the close of the Time Warner Cable deal and noted at that time that "everything was on track" regarding the merger. The Wall Street Journal reported on September 30 that the FCC pushed for media companies to submit details of their programming agreements with Comcast prior to the Time Warner Cable deal. The FCC announced three days later that it extended time for the companies to file their replies on Comcast regarding the merger. On October 8, Comcast Shareholders approved stock issuance for the Time Warner Cable deal and the next day, Time Warner Cable stockholders approved the Comcast merger deal. STREET RESEARCH: Analysts remained fairly quiet on Comcast throughout the quarter. On September 9, UBS raised its price target on Comcast to $72 from $60 given its strong underlying fundamentals and the expected free cash flow accretion from the Time Warner Cable deal. The firm also said it expected Comcast to accelerate its stock buyback and increase its dividend. UBS kept its Buy rating on the stock. On October 17, Goldman Sachs said that Comcast was its top large cap pick into the earnings report given steady fundamentals, moderated expectations, and valuation. The firm maintained the stock with a Buy rating and a $64 price target. PRICE ACTION: Since the first day of trade following its Q2 report on July 22, shares of Comcast are down about 3.5%. Since it announced its deal with Time Warner Cable on February 13, shares of the media company have fallen just under 6%. In late-morning trade ahead of tomorrow’s Q3 report, shares of Comcast are down fractionally.
11:14 EDTLTMHigh option volume stocks
Subscribe for More Information
07:35 EDTMRKCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information
07:02 EDTALKSAlkermes aripiprazole lauroxil NDA accepted for filing by FDA
Subscribe for More Information
06:14 EDTNFLXStocks with implied volatility below IV index mean; XLNX NFLX
Stocks with implied volatility below IV index mean; Xilinx (XLNX) 24, Netflix (NFLX) 35 according to iVolatility.
October 21, 2014
16:00 EDTNFLXOptions Update; October 21, 2014
Subscribe for More Information
10:00 EDTCTRPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:08 EDTCTRPCtrip.com initiated with a Buy at Citigroup
Subscribe for More Information
07:54 EDTALKSLeerink a buyer of Alkermes, ImmunoGen, Incyte
Subscribe for More Information
06:27 EDTNFLXStocks with implied volatility below IV index mean; EBAY NFLX
Stocks with implied volatility below IV index mean; eBay (EBAY) 26, Netflix (NFLX) 38 according to iVolatility.
06:09 EDTMATMEGA brands announces global partnership with UP&L
Subscribe for More Information
October 20, 2014
16:24 EDTCTRPPriceline raises stake in Ctrip.com to 7.9% from 6.88%
16:00 EDTNFLXOptions Update; October 20, 2014
Subscribe for More Information
12:36 EDTMATOptions with decreasing implied volatility
Subscribe for More Information
12:01 EDTNFLXNetflix, Amazon recomended as short ideas by Fred Wilson, Bloomberg reports
Subscribe for More Information
08:06 EDTMRKMerck, Sanofi unit announce pediatric hexavalent vaccine BLA
Subscribe for More Information
07:34 EDTMRKAdvaxis names Mauro Chief Medical Officer
Advaxis (ADXS) announced that it has appointed David Mauro, as executive vice president, Chief Medical Officer Mauro most recently served as executive director, section head oncology clinical development at Merck (MRK). In connection with his appointment, Mauro received a one-time inducement award of 165K restricted shares, of which 55K are fully vested and as of the grant date. The remaining shares vest annually over a two-year period.
07:19 EDTMRKIBC Life Sciences to hold a conference
Subscribe for More Information
07:11 EDTMRKAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
06:01 EDTNFLXStocks with implied volatility below IV index mean; EBAY NFLX
Stocks with implied volatility below IV index mean; eBay (EBAY) 27, Netflix (NFLX) 40 according to iVolatility.
October 17, 2014
16:55 EDTNFLXStocks end volatile week lower amid oil price plunge
Subscribe for More Information
12:38 EDTNFLXNetflix shares 'so far underpriced right now its amazing,' says Cuban
Subscribe for More Information
12:17 EDTNFLXMark Cuban says buying Netflix shares, sees company as M&A target
Subscribe for More Information
11:38 EDTNFLXCuban say buying Netflix stock, predicts 'someone will try to buy them'
Subscribe for More Information
10:58 EDTNFLXHBO streaming service may cost around $15 a month, The Information reports
Subscribe for More Information
10:00 EDTMCKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:38 EDTNFLXActive equity options trading on
Subscribe for More Information
09:07 EDTTSNProtein stock pullback on Sanderson comments overdone, says BMO Capital
BMO Capital views yesterday's decline in Sanderson Farms (SAFM), Pilgrim's Pride (PPC) and Tyson Foods (TSN) as an overreaction to Sanderson's comments regarding breast prices falling to year-ago levels for the next four months. BMO notes that breast prices always dip in the fall. Following Sanderson's investor day, BMO said it sees a greater probability of chicken margins remaining at near-record levels in 2015. It keeps an Outperform rating on the stock.
07:58 EDTMRKDeutsche Bank specialty pharma analyst holds analyst/industry conference call
Specialty Pharmaceuticals Analyst Gilbert provides of preview of The Improved Reduction of Outcomes: Vytorin Efficacy Internal Study (IMPROVE-IT) on an Analyst/Industry conference call to be held on October 17 at 10 am.
07:48 EDTMATMattel looks to maintain margins in low to mid-50% range in near term
Subscribe for More Information
07:39 EDTTSNChicken stock sell-off yesterday overdone, says JPMorgan
Subscribe for More Information
06:24 EDTNFLXStocks with implied volatility below IV index mean; HPQ NFLX
Stocks with implied volatility below IV index mean; HP (HPQ) 31, Netflix (NFLX) 40 according to iVolatility.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use